Skip to content
November 03, 2026

Equity.Guru

Investment information for the new generation

Search

Ibogaine

1 December 2023 Lophos Pharmaceuticals (MESC.C) expands licensing to include just about…
1 December 2023
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all…
There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics…
11 February 2022 Metaverse and mental health therapy – another psychedelics sector…
11 February 2022
Metaverse and mental health therapy – another psychedelics sector roundup
Back in October, Zuckerberg, seeing plunging user numbers and fading growth, desperately renamed Facebook, once the world’s foremost purveyor of misinformation and unethical aggregator of personal data, to Meta,…
28 January 2022 Do ethics matter when you invest? – another psychedelics…
28 January 2022
Do ethics matter when you invest? – another psychedelics sector…
Environmental, Social and Governance (ESG) focused investment is a relatively new accepted method for socially conscious investors to allocate their investment capital in public/private companies that align with their…
14 January 2022 What does Health Canada’s amendment proposal mean for psychedelics?…
14 January 2022
What does Health Canada’s amendment proposal mean for psychedelics? –…
Health Canada stepped up to the plate back in December with a Notice of Intent to amend the Food and Drug Regulations and the Narcotic Control Regulations to restore…
30 December 2021 If I had a billion dollars: psychedelics sector edition…
30 December 2021
If I had a billion dollars: psychedelics sector edition
The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble,…
10 December 2021 Can we trust the science of psychedelics? Another sector…
10 December 2021
Can we trust the science of psychedelics? Another sector roundup.
Psychedelics have showed tremendous potential in treating neurological conditions such as major depressive disorder, PTSD, ALS, and generalized anxiety. Investors jumped on the opportunity, sending market values skyrocketing. It’s…
3 December 2021 DEA ups the ante for psychedelics research – another…
3 December 2021
DEA ups the ante for psychedelics research – another psychedelics…
The world’s first psychedelic ETF, PSYK, is an industry bellwether which indicates the psychedelics space continues to take a drubbing since the ETF launched in January.  The fund closed…
24 November 2021 Small cap psychedelics stocks – Today’s Idea Gaalen Engen…
24 November 2021
Small cap psychedelics stocks – Today’s Idea
The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in the sector that have…
24 November 2021 Canadian Psychedelic Stocks – To Invest or Not Reza…
24 November 2021
Canadian Psychedelic Stocks – To Invest or Not
In this episode, we take a look at 3 Canadian psychedelic stocks with potential: MYND Life Science (MYND.C), Mind Cure Health Inc. (MCUR.C), NeonMind Biosciences (NEON.C). We briefly go…
19 November 2021 Psychedelics conference fever – another sector roundup Gaalen Engen…
19 November 2021
Psychedelics conference fever – another sector roundup
Whether you’re curious about taking a psychedelics investment trip or a tie-dyed-in-the-wool public market backer, psychedelics conferences are the best way to keep on top of industry advances and…